Invention Grant
- Patent Title: Use of HDL-related molecules to treat and prevent proinflammatory conditions
-
Application No.: US15004604Application Date: 2016-01-22
-
Publication No.: US10208103B2Publication Date: 2019-02-19
- Inventor: Robin Farias-Eisner , Srinivasa T. Reddy
- Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Applicant Address: US CA Oakland
- Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee Address: US CA Oakland
- Agency: canady + lortz LLP
- Agent Karen S. Canady
- Main IPC: C07K14/775
- IPC: C07K14/775 ; A61K38/16 ; A61K38/17 ; A61K38/00

Abstract:
Molecules and compositions are described for use in the treatment and prevention of pro-inflammatory conditions. HDL-related molecules, including ApoA-I, bovine HDL and HDL mimetics, in particular, are demonstrated to prevent UV-induced cell death and oxidative stress in skin cells and to inhibit tumor growth and development in a variety of cancers. HDL-related molecules can be used as an oral supplement and in other compositions to prevent or treat pro-inflammatory skin conditions and systemic proinflammatory conditions, including Alzheimer's disease and various cancers.
Public/Granted literature
- US20170204160A1 USE OF HDL-RELATED MOLECULES TO TREAT AND PREVENT PROINFLAMMATORY CONDITIONS Public/Granted day:2017-07-20
Information query